SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...

DelveInsight's Hepatocellular Carcinoma pipeline report depicts a robust space with 90+ active players working to develop 95+ pipeline therapies for Hepatocellular Carcinoma treatment.

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

The risk of dying from the most common form of primary liver cancer is approximately 30% higher for patients with low ...

A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...

Berlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

Alexis McCarthy, a freshman at South Glens Falls High, is recovering from a successful surgery to remove a rare childhood ...

Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge ...